PE20030472A1 - Formulacion solida para utilizar como medicamento a base de un derivado de piperazinurea - Google Patents
Formulacion solida para utilizar como medicamento a base de un derivado de piperazinureaInfo
- Publication number
- PE20030472A1 PE20030472A1 PE2002001027A PE2002001027A PE20030472A1 PE 20030472 A1 PE20030472 A1 PE 20030472A1 PE 2002001027 A PE2002001027 A PE 2002001027A PE 2002001027 A PE2002001027 A PE 2002001027A PE 20030472 A1 PE20030472 A1 PE 20030472A1
- Authority
- PE
- Peru
- Prior art keywords
- polyuble
- cellulose
- methyl
- refers
- solid formulation
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000001913 cellulose Substances 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 abstract 1
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- -1 FUMARIC Chemical class 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 150000007945 N-acyl ureas Chemical class 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- VOWXPORNXKKEQO-UHFFFAOYSA-N [1-[(4-fluorophenyl)methyl]-3-methylpiperazin-2-ylidene]methanone Chemical compound O=C=C1C(C)NCCN1CC1=CC=C(F)C=C1 VOWXPORNXKKEQO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 abstract 1
- 235000010980 cellulose Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 abstract 1
- 229910000393 dicalcium diphosphate Inorganic materials 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical class O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 abstract 1
- 229920000515 polycarbonate Polymers 0.000 abstract 1
- 239000004417 polycarbonate Substances 0.000 abstract 1
- 229920000728 polyester Polymers 0.000 abstract 1
- 239000004814 polyurethane Substances 0.000 abstract 1
- 229920002635 polyurethane Polymers 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10152351A DE10152351B4 (de) | 2001-10-18 | 2001-10-18 | Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030472A1 true PE20030472A1 (es) | 2003-06-16 |
Family
ID=7703496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002001027A PE20030472A1 (es) | 2001-10-18 | 2002-10-17 | Formulacion solida para utilizar como medicamento a base de un derivado de piperazinurea |
Country Status (23)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3909056B2 (ja) | 2001-06-27 | 2007-04-25 | スミスクライン ビーチャム コーポレーション | ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類 |
| EP1749519A1 (de) * | 2005-08-05 | 2007-02-07 | Schering Aktiengesellschaft | Arzneiform mit Retardtierter pH-unabhängiger Wirkstofffreisetzung für Wirkstoffe mit starker pH-abhängiger Löslichkeit |
| AU2007242077B2 (en) * | 2006-04-26 | 2013-11-14 | Alphapharm Pty Ltd | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| KR101654582B1 (ko) | 2016-05-12 | 2016-09-06 | 그린로드(주) | 원뿔형 부유 고분자 필터, 및 그의 제조장치 및 제조방법, 및 그를 포함하는 수처리 필터 |
| RU2729223C1 (ru) * | 2020-05-13 | 2020-08-05 | Мераб Георгиевич Чикобава | Дозированная форма для амплификации нуклеиновых кислот |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1246383B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per il mascheramento del sapore di farmaci |
| FR2668945B1 (fr) * | 1990-11-12 | 1993-02-19 | Theramex | Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus. |
| US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
| US6004996A (en) * | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
| US6207665B1 (en) * | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
| ATE337307T1 (de) * | 1998-02-05 | 2006-09-15 | Pfizer Prod Inc | Neue dihydroxyhexansäurederivate |
| EP1027885B1 (en) * | 1999-02-09 | 2008-07-09 | Pfizer Products Inc. | Basic drug compositions with enhanced bioavailability |
-
2001
- 2001-10-18 DE DE10152351A patent/DE10152351B4/de not_active Expired - Fee Related
-
2002
- 2002-10-07 RS YU32204A patent/RS32204A/sr unknown
- 2002-10-07 CA CA002463951A patent/CA2463951A1/en not_active Abandoned
- 2002-10-07 MX MXPA04003522A patent/MXPA04003522A/es unknown
- 2002-10-07 HR HR20040435A patent/HRP20040435A2/hr not_active Application Discontinuation
- 2002-10-07 NZ NZ532287A patent/NZ532287A/en unknown
- 2002-10-07 RU RU2004115328/15A patent/RU2311172C2/ru not_active IP Right Cessation
- 2002-10-07 PL PL02367987A patent/PL367987A1/xx not_active Application Discontinuation
- 2002-10-07 AU AU2002333896A patent/AU2002333896B2/en not_active Ceased
- 2002-10-07 JP JP2003537604A patent/JP2005506365A/ja active Pending
- 2002-10-07 KR KR10-2004-7005591A patent/KR20040047920A/ko not_active Ceased
- 2002-10-07 EP EP02801884A patent/EP1435917A1/de not_active Withdrawn
- 2002-10-07 IL IL16116602A patent/IL161166A0/xx unknown
- 2002-10-07 BR BR0213340-7A patent/BR0213340A/pt not_active IP Right Cessation
- 2002-10-07 WO PCT/EP2002/011229 patent/WO2003035037A1/de not_active Ceased
- 2002-10-07 CN CNA02820512XA patent/CN1571660A/zh active Pending
- 2002-10-17 UY UY27500A patent/UY27500A1/es not_active Application Discontinuation
- 2002-10-17 PE PE2002001027A patent/PE20030472A1/es not_active Application Discontinuation
- 2002-10-18 AR ARP020103929A patent/AR037111A1/es unknown
-
2004
- 2004-05-13 CO CO04044345A patent/CO5580740A2/es not_active Application Discontinuation
- 2004-05-14 NO NO20042022A patent/NO20042022L/no not_active Application Discontinuation
- 2004-05-17 ZA ZA200403781A patent/ZA200403781B/en unknown
- 2004-05-17 EC EC2004005108A patent/ECSP045108A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE10152351B4 (de) | 2005-09-22 |
| CN1571660A (zh) | 2005-01-26 |
| MXPA04003522A (es) | 2004-07-23 |
| AU2002333896B2 (en) | 2007-07-26 |
| NO20042022L (no) | 2004-05-14 |
| AR037111A1 (es) | 2004-10-20 |
| PL367987A1 (en) | 2005-03-21 |
| AU2002333896A2 (en) | 2003-05-06 |
| RU2004115328A (ru) | 2005-06-10 |
| EP1435917A1 (de) | 2004-07-14 |
| CA2463951A1 (en) | 2003-05-01 |
| HRP20040435A2 (en) | 2005-06-30 |
| RU2311172C2 (ru) | 2007-11-27 |
| BR0213340A (pt) | 2004-10-05 |
| JP2005506365A (ja) | 2005-03-03 |
| DE10152351A1 (de) | 2003-05-08 |
| WO2003035037A1 (de) | 2003-05-01 |
| KR20040047920A (ko) | 2004-06-05 |
| UY27500A1 (es) | 2003-06-30 |
| NZ532287A (en) | 2007-04-27 |
| RS32204A (sr) | 2006-10-27 |
| CO5580740A2 (es) | 2005-11-30 |
| IL161166A0 (en) | 2004-08-31 |
| ECSP045108A (es) | 2004-06-28 |
| ZA200403781B (en) | 2004-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4108750B2 (ja) | N−プロパルギル−1−アミノインダンを含有する安定な組成物 | |
| AU2304300A (en) | Indole derivatives and their use as mcp-1 receptor antagonists | |
| TW200503775A (en) | Pharmaceutical composition and method for treating | |
| MA29171B1 (fr) | Formulation a compression directe et procede associe | |
| KR20180109992A (ko) | Jak 키나아제 억제제 또는 약학적으로 허용가능한 그의 염을 함유하는 약학적 조성물 | |
| NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| JP2018154596A (ja) | アジルサルタン含有固形医薬組成物 | |
| MX2022016263A (es) | Derivados de ciclobutil-urea. | |
| CA2441785A1 (en) | Fast disintegrating meloxicam tablet | |
| US20040234596A1 (en) | Fast disintegrating meloxicam tablet | |
| MX2022015495A (es) | Inhibidores de cinasa relacionada con el gen a nunca en mitosis (nek7). | |
| EP1843754B1 (en) | New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance | |
| CA2490335A1 (en) | Pharmaceutical composition as solid dosage form and method for manufacturing thereof | |
| BG106516A (en) | Pharmaceutical agent comprising a benzamide derivative as active ingredient | |
| TW200606164A (en) | New compounds | |
| CA2525700A1 (en) | S-(-)-amlodipine nicotinate and process for the preparation thereof | |
| WO2000053162A1 (en) | Controlled-release compositions of betahistine | |
| SI8710406B (sl) | Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo | |
| JP3995414B2 (ja) | 安定な医薬組成物 | |
| WO2005070464A2 (en) | A tablet formulation of clopidogrel bisulphate | |
| NZ510115A (en) | Tricyclic delta3-piperidines as alpha2-antagonists useful in the treatment of depression and Parkinson's disease | |
| TW200800984A (en) | New compounds | |
| KR100760448B1 (ko) | 벤즈아미딘 유도체 함유 조성물 및 벤즈아미딘 유도체의안정화 방법 | |
| SK18582000A3 (sk) | Obalené cyklofosfamidové tablety | |
| JPH11349479A (ja) | 安定なマレイン酸エナラプリル錠剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |